

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.08321283 |
| 2 | maturation of SSU-rRNA (GO:0030490) | 4.91587887 |
| 3 | ribosome assembly (GO:0042255) | 4.82727215 |
| 4 | mitotic metaphase plate congression (GO:0007080) | 4.80930604 |
| 5 | purine nucleobase biosynthetic process (GO:0009113) | 4.76873609 |
| 6 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.59362154 |
| 7 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.43905937 |
| 8 | nucleobase biosynthetic process (GO:0046112) | 4.43304448 |
| 9 | NIK/NF-kappaB signaling (GO:0038061) | 4.38347987 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.38190163 |
| 11 | ribosome biogenesis (GO:0042254) | 4.34080165 |
| 12 | formation of translation preinitiation complex (GO:0001731) | 4.22963523 |
| 13 | DNA strand elongation (GO:0022616) | 4.19386019 |
| 14 | DNA replication checkpoint (GO:0000076) | 4.07546186 |
| 15 | proteasome assembly (GO:0043248) | 4.02526814 |
| 16 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.02430176 |
| 17 | amino acid salvage (GO:0043102) | 4.02397999 |
| 18 | L-methionine salvage (GO:0071267) | 4.02397999 |
| 19 | L-methionine biosynthetic process (GO:0071265) | 4.02397999 |
| 20 | DNA replication initiation (GO:0006270) | 3.99427957 |
| 21 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.99385198 |
| 22 | GDP-mannose metabolic process (GO:0019673) | 3.96357428 |
| 23 | metaphase plate congression (GO:0051310) | 3.95578351 |
| 24 | protein maturation by protein folding (GO:0022417) | 3.93808574 |
| 25 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.90748579 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.89830147 |
| 27 | spliceosomal snRNP assembly (GO:0000387) | 3.87244021 |
| 28 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.85320183 |
| 29 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.85320183 |
| 30 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.85074252 |
| 31 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.83991433 |
| 32 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.76428140 |
| 33 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.75967027 |
| 34 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.75130192 |
| 35 | rRNA modification (GO:0000154) | 3.71162952 |
| 36 | spliceosomal complex assembly (GO:0000245) | 3.69700286 |
| 37 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.68780586 |
| 38 | termination of RNA polymerase III transcription (GO:0006386) | 3.68780586 |
| 39 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.67362217 |
| 40 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.66797367 |
| 41 | amino sugar catabolic process (GO:0046348) | 3.62125272 |
| 42 | rRNA processing (GO:0006364) | 3.60872376 |
| 43 | ribosomal large subunit biogenesis (GO:0042273) | 3.50223517 |
| 44 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.49549384 |
| 45 | ribosomal small subunit assembly (GO:0000028) | 3.49343151 |
| 46 | rRNA metabolic process (GO:0016072) | 3.47493670 |
| 47 | pseudouridine synthesis (GO:0001522) | 3.46611678 |
| 48 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.45458883 |
| 49 | negative regulation of ligase activity (GO:0051352) | 3.45458883 |
| 50 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.41184017 |
| 51 | translational initiation (GO:0006413) | 3.39003110 |
| 52 | regulation of spindle organization (GO:0090224) | 3.38393089 |
| 53 | response to peptidoglycan (GO:0032494) | 3.36159350 |
| 54 | telomere maintenance via recombination (GO:0000722) | 3.35937210 |
| 55 | maturation of 5.8S rRNA (GO:0000460) | 3.34901853 |
| 56 | protein localization to kinetochore (GO:0034501) | 3.34258205 |
| 57 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.33809882 |
| 58 | methionine biosynthetic process (GO:0009086) | 3.32043785 |
| 59 | mitotic nuclear envelope disassembly (GO:0007077) | 3.30530616 |
| 60 | DNA replication-independent nucleosome organization (GO:0034724) | 3.30089981 |
| 61 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.30089981 |
| 62 | mature B cell differentiation involved in immune response (GO:0002313) | 3.28952230 |
| 63 | protein K6-linked ubiquitination (GO:0085020) | 3.28808463 |
| 64 | positive thymic T cell selection (GO:0045059) | 3.27535604 |
| 65 | cytidine deamination (GO:0009972) | 3.26344369 |
| 66 | cytidine metabolic process (GO:0046087) | 3.26344369 |
| 67 | cytidine catabolic process (GO:0006216) | 3.26344369 |
| 68 | IMP biosynthetic process (GO:0006188) | 3.23689703 |
| 69 | positive regulation of ligase activity (GO:0051351) | 3.23666878 |
| 70 | folic acid metabolic process (GO:0046655) | 3.21105232 |
| 71 | establishment of chromosome localization (GO:0051303) | 3.20505296 |
| 72 | UV protection (GO:0009650) | 3.19291132 |
| 73 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.18962102 |
| 74 | CENP-A containing nucleosome assembly (GO:0034080) | 3.18829464 |
| 75 | viral transcription (GO:0019083) | 3.15335117 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.15033915 |
| 77 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.14882684 |
| 78 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.14882684 |
| 79 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.14882684 |
| 80 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.14202065 |
| 81 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.13627261 |
| 82 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.13627261 |
| 83 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.13459552 |
| 84 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.13459552 |
| 85 | pyrimidine-containing compound salvage (GO:0008655) | 3.13369456 |
| 86 | pyrimidine nucleoside salvage (GO:0043097) | 3.13369456 |
| 87 | methionine metabolic process (GO:0006555) | 3.11967869 |
| 88 | translational termination (GO:0006415) | 3.11026514 |
| 89 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.09024953 |
| 90 | mitotic recombination (GO:0006312) | 3.09023812 |
| 91 | adenosine receptor signaling pathway (GO:0001973) | 3.08955026 |
| 92 | actin nucleation (GO:0045010) | 3.08613816 |
| 93 | telomere maintenance via telomere lengthening (GO:0010833) | 3.08039285 |
| 94 | 7-methylguanosine mRNA capping (GO:0006370) | 3.07283664 |
| 95 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.05921579 |
| 96 | cell cycle G1/S phase transition (GO:0044843) | 3.05921579 |
| 97 | chromatin remodeling at centromere (GO:0031055) | 3.05771382 |
| 98 | translational elongation (GO:0006414) | 3.04604032 |
| 99 | microtubule depolymerization (GO:0007019) | 3.04407502 |
| 100 | nuclear envelope disassembly (GO:0051081) | 3.04123364 |
| 101 | membrane disassembly (GO:0030397) | 3.04123364 |
| 102 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.03887543 |
| 103 | RNA splicing, via transesterification reactions (GO:0000375) | 3.03406693 |
| 104 | negative regulation of chromosome segregation (GO:0051985) | 3.03349936 |
| 105 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.03039918 |
| 106 | deoxyribonucleotide catabolic process (GO:0009264) | 3.02420789 |
| 107 | B cell mediated immunity (GO:0019724) | 3.01694605 |
| 108 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.00398370 |
| 109 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.00268474 |
| 110 | negative regulation of sister chromatid segregation (GO:0033046) | 3.00268474 |
| 111 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.00268474 |
| 112 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.00268474 |
| 113 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 3.00109184 |
| 114 | mRNA splicing, via spliceosome (GO:0000398) | 3.00109184 |
| 115 | protein deneddylation (GO:0000338) | 2.99936332 |
| 116 | glycosphingolipid catabolic process (GO:0046479) | 2.98518424 |
| 117 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.96417826 |
| 118 | mitotic spindle assembly checkpoint (GO:0007094) | 2.94217743 |
| 119 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.93379305 |
| 120 | postreplication repair (GO:0006301) | 2.93244159 |
| 121 | histone exchange (GO:0043486) | 2.93101277 |
| 122 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.93054990 |
| 123 | protein localization to chromosome, centromeric region (GO:0071459) | 2.93014769 |
| 124 | protein complex localization (GO:0031503) | 2.91944273 |
| 125 | negative regulation of interleukin-12 production (GO:0032695) | 2.91804020 |
| 126 | 7-methylguanosine RNA capping (GO:0009452) | 2.91256484 |
| 127 | RNA capping (GO:0036260) | 2.91256484 |
| 128 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.90817130 |
| 129 | positive regulation of T cell apoptotic process (GO:0070234) | 2.90478580 |
| 130 | deoxyribose phosphate catabolic process (GO:0046386) | 2.89343903 |
| 131 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.85942884 |
| 132 | regulation of superoxide anion generation (GO:0032928) | 2.85647492 |
| 133 | pinocytosis (GO:0006907) | 2.85345973 |
| 134 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.83895084 |
| 135 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.82530627 |
| 136 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.82530627 |
| 137 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.82008678 |
| 138 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.81733312 |
| 139 | metallo-sulfur cluster assembly (GO:0031163) | 2.80865676 |
| 140 | iron-sulfur cluster assembly (GO:0016226) | 2.80865676 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79200954 |
| 142 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.78374072 |
| 143 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.78355614 |
| 144 | neutrophil activation involved in immune response (GO:0002283) | 2.75150483 |
| 145 | ribosomal small subunit biogenesis (GO:0042274) | 2.74417718 |
| 146 | response to interferon-beta (GO:0035456) | 2.70739807 |
| 147 | nucleotide salvage (GO:0043173) | 2.70651613 |
| 148 | cellular response to arsenic-containing substance (GO:0071243) | 2.70071820 |
| 149 | myeloid dendritic cell activation (GO:0001773) | 2.69644570 |
| 150 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.69398795 |
| 151 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.69119470 |
| 152 | T cell migration (GO:0072678) | 2.66248453 |
| 153 | myeloid dendritic cell differentiation (GO:0043011) | 2.66053706 |
| 154 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.65543844 |
| 155 | glycolipid catabolic process (GO:0019377) | 2.63205492 |
| 156 | barbed-end actin filament capping (GO:0051016) | 2.61612805 |
| 157 | activation of MAPKKK activity (GO:0000185) | 2.60013140 |
| 158 | lipopolysaccharide metabolic process (GO:0008653) | 2.59731077 |
| 159 | purine nucleotide salvage (GO:0032261) | 2.57453934 |
| 160 | modulation by symbiont of host cellular process (GO:0044068) | 2.55610757 |
| 161 | regulation of defense response to virus by virus (GO:0050690) | 2.55590308 |
| 162 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.54519590 |
| 163 | modulation by virus of host process (GO:0019054) | 2.54189502 |
| 164 | regulation of mitochondrial membrane potential (GO:0051881) | 2.54102636 |
| 165 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.53757256 |
| 166 | regulation of lymphocyte migration (GO:2000401) | 2.53377758 |
| 167 | positive regulation of B cell differentiation (GO:0045579) | 2.52599016 |
| 168 | negative regulation of viral genome replication (GO:0045071) | 2.51556120 |
| 169 | nuclear envelope reassembly (GO:0031468) | 2.51281874 |
| 170 | mitotic nuclear envelope reassembly (GO:0007084) | 2.51281874 |
| 171 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.50713511 |
| 172 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.49776238 |
| 173 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.48945705 |
| 174 | pentose metabolic process (GO:0019321) | 2.48850436 |
| 175 | monocyte chemotaxis (GO:0002548) | 2.46818504 |
| 176 | regulation of mononuclear cell migration (GO:0071675) | 2.46457663 |
| 177 | positive regulation of lymphocyte migration (GO:2000403) | 2.45892992 |
| 178 | type I interferon signaling pathway (GO:0060337) | 2.44982412 |
| 179 | cellular response to type I interferon (GO:0071357) | 2.44982412 |
| 180 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.44842267 |
| 181 | deoxyribose phosphate metabolic process (GO:0019692) | 2.44490840 |
| 182 | negative regulation of B cell apoptotic process (GO:0002903) | 2.42454390 |
| 183 | myeloid cell activation involved in immune response (GO:0002275) | 2.40721650 |
| 184 | granulocyte activation (GO:0036230) | 2.39140321 |
| 185 | response to type I interferon (GO:0034340) | 2.39087119 |
| 186 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.38140998 |
| 187 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.37780228 |
| 188 | lipoxygenase pathway (GO:0019372) | 2.37426993 |
| 189 | regulation of mast cell degranulation (GO:0043304) | 2.35055341 |
| 190 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.34789785 |
| 191 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.34789785 |
| 192 | modulation by symbiont of host immune response (GO:0052553) | 2.34789785 |
| 193 | positive regulation by symbiont of host defense response (GO:0052509) | 2.34789785 |
| 194 | modulation by symbiont of host defense response (GO:0052031) | 2.34789785 |
| 195 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.34789785 |
| 196 | phagosome maturation (GO:0090382) | 2.32613405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.72507502 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.06204687 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.99766040 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.35243211 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.23712816 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.19963550 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.13398611 |
| 8 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.98831699 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.98662289 |
| 10 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.96310509 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.90293578 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.82316099 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.80432158 |
| 14 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.77325768 |
| 15 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.77058330 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.76034716 |
| 17 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52871615 |
| 18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.46873580 |
| 19 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.46264440 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.32656529 |
| 21 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.31606318 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.25848834 |
| 23 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.21466133 |
| 24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.20818581 |
| 25 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.15946115 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.12164483 |
| 27 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.11794998 |
| 28 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.04486706 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.98744615 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.95414823 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.93194783 |
| 32 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91589802 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.90899141 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.89355304 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.86304966 |
| 36 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.85739509 |
| 37 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.84645340 |
| 38 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82418735 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81164852 |
| 40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80798451 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78911913 |
| 42 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.78772093 |
| 43 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.73987027 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73199588 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72625794 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.71280590 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70310416 |
| 48 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69672083 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.69072312 |
| 50 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.68916767 |
| 51 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67782451 |
| 52 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.66592099 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.66489450 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.66118235 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65662886 |
| 56 | P68_20966046_ChIP-Seq_HELA_Human | 1.62677372 |
| 57 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.62407691 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62196289 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.61117251 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.59900734 |
| 61 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59204961 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.58743003 |
| 63 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57628377 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55935717 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.55898667 |
| 66 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.55199345 |
| 67 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.54816332 |
| 68 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.53016054 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52182344 |
| 70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.50593244 |
| 71 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50375305 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.49615176 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48921300 |
| 74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48446879 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48390291 |
| 76 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47232696 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46087938 |
| 78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.45642524 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42308198 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41961186 |
| 81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.40764855 |
| 82 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40505727 |
| 83 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36132918 |
| 84 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.35369696 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34835810 |
| 86 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33643422 |
| 87 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.33582554 |
| 88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33336479 |
| 89 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32155136 |
| 90 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.31934395 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31763794 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.31625259 |
| 93 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31336729 |
| 94 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.30653790 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29459490 |
| 96 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28023393 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26077548 |
| 98 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23510712 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21902359 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21493023 |
| 101 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18171781 |
| 102 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17659620 |
| 103 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.17638979 |
| 104 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17366702 |
| 105 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17103555 |
| 106 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16801726 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16775876 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16747836 |
| 109 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.15839859 |
| 110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15478084 |
| 111 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15264683 |
| 112 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14545405 |
| 113 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14126856 |
| 114 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13421100 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12228617 |
| 116 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12005240 |
| 117 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11516315 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11029759 |
| 119 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.08900775 |
| 120 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08867220 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08413504 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08055040 |
| 123 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07839728 |
| 124 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07585246 |
| 125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07457236 |
| 126 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07410645 |
| 127 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06674753 |
| 128 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.05752555 |
| 129 | SA1_27219007_Chip-Seq_Bcells_Human | 1.05635310 |
| 130 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.05613984 |
| 131 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04964755 |
| 132 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04962792 |
| 133 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.04830717 |
| 134 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.04735874 |
| 135 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.04440015 |
| 136 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.04359315 |
| 137 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02665712 |
| 138 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02521958 |
| 139 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01836139 |
| 140 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00907324 |
| 141 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.99368345 |
| 142 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99223050 |
| 143 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94667270 |
| 144 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.93007402 |
| 145 | * NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.92969021 |
| 146 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.90761860 |
| 147 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90004269 |
| 148 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88233146 |
| 149 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88082765 |
| 150 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.87928569 |
| 151 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87445562 |
| 152 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.87347862 |
| 153 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.86897010 |
| 154 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.85792975 |
| 155 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85396138 |
| 156 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85187692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 6.53695416 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.86316597 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.76297983 |
| 4 | MP0004957_abnormal_blastocyst_morpholog | 4.57258212 |
| 5 | MP0003077_abnormal_cell_cycle | 4.03800274 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.95257047 |
| 7 | MP0002653_abnormal_ependyma_morphology | 3.46066299 |
| 8 | MP0008058_abnormal_DNA_repair | 3.31162389 |
| 9 | MP0003436_decreased_susceptibility_to | 3.17496867 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.99582432 |
| 11 | MP0005671_abnormal_response_to | 2.88583902 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.79350678 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.70651418 |
| 14 | MP0009840_abnormal_foam_cell | 2.69828180 |
| 15 | MP0006082_CNS_inflammation | 2.67556616 |
| 16 | MP0003718_maternal_effect | 2.60238523 |
| 17 | MP0008932_abnormal_embryonic_tissue | 2.59281027 |
| 18 | MP0009785_altered_susceptibility_to | 2.55591110 |
| 19 | MP0001730_embryonic_growth_arrest | 2.52269249 |
| 20 | MP0005025_abnormal_response_to | 2.49645750 |
| 21 | MP0003075_altered_response_to | 2.49628319 |
| 22 | MP0008007_abnormal_cellular_replicative | 2.45783202 |
| 23 | MP0003123_paternal_imprinting | 2.35628172 |
| 24 | MP0002419_abnormal_innate_immunity | 2.32702900 |
| 25 | MP0001835_abnormal_antigen_presentation | 2.31783379 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 2.28020500 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.22454816 |
| 28 | MP0000350_abnormal_cell_proliferation | 2.18426440 |
| 29 | MP0004510_myositis | 2.14058924 |
| 30 | MP0008057_abnormal_DNA_replication | 2.13610972 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 2.11509915 |
| 32 | MP0002723_abnormal_immune_serum | 2.09134374 |
| 33 | MP0003172_abnormal_lysosome_physiology | 2.07424529 |
| 34 | MP0000604_amyloidosis | 2.02854294 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.99625176 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.99508077 |
| 37 | MP0001819_abnormal_immune_cell | 1.95807728 |
| 38 | MP0000343_altered_response_to | 1.94755892 |
| 39 | MP0001853_heart_inflammation | 1.94469524 |
| 40 | MP0005451_abnormal_body_composition | 1.91488507 |
| 41 | MP0005387_immune_system_phenotype | 1.84473592 |
| 42 | MP0001790_abnormal_immune_system | 1.84473592 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.82464073 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.82464073 |
| 45 | MP0001800_abnormal_humoral_immune | 1.79753715 |
| 46 | MP0000685_abnormal_immune_system | 1.79240918 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.77486790 |
| 48 | MP0001672_abnormal_embryogenesis/_devel | 1.75904928 |
| 49 | MP0005380_embryogenesis_phenotype | 1.75904928 |
| 50 | MP0003786_premature_aging | 1.72818226 |
| 51 | MP0001697_abnormal_embryo_size | 1.70832126 |
| 52 | MP0006292_abnormal_olfactory_placode | 1.69978463 |
| 53 | MP0008260_abnormal_autophagy | 1.69012436 |
| 54 | MP0002080_prenatal_lethality | 1.68126676 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.66250383 |
| 56 | MP0003448_altered_tumor_morphology | 1.65578757 |
| 57 | MP0003329_amyloid_beta_deposits | 1.64460098 |
| 58 | MP0000313_abnormal_cell_death | 1.61501384 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.56730368 |
| 60 | MP0004947_skin_inflammation | 1.56667890 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.54387535 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.51686828 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.51410610 |
| 64 | MP0003984_embryonic_growth_retardation | 1.50137960 |
| 65 | MP0002405_respiratory_system_inflammati | 1.47626123 |
| 66 | MP0002088_abnormal_embryonic_growth/wei | 1.44869156 |
| 67 | MP0000490_abnormal_crypts_of | 1.42754369 |
| 68 | MP0002210_abnormal_sex_determination | 1.39674347 |
| 69 | MP0009764_decreased_sensitivity_to | 1.39040586 |
| 70 | MP0002132_abnormal_respiratory_system | 1.38574749 |
| 71 | MP0000015_abnormal_ear_pigmentation | 1.38137677 |
| 72 | MP0002085_abnormal_embryonic_tissue | 1.37606360 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 1.37554789 |
| 74 | MP0008469_abnormal_protein_level | 1.36505433 |
| 75 | MP0005166_decreased_susceptibility_to | 1.34312749 |
| 76 | MP0010307_abnormal_tumor_latency | 1.32574428 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.32535767 |
| 78 | MP0009278_abnormal_bone_marrow | 1.31899990 |
| 79 | MP0003763_abnormal_thymus_physiology | 1.30315266 |
| 80 | MP0000750_abnormal_muscle_regeneration | 1.27534614 |
| 81 | MP0005423_abnormal_somatic_nervous | 1.25907500 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 1.25408247 |
| 83 | MP0002084_abnormal_developmental_patter | 1.25022669 |
| 84 | MP0010030_abnormal_orbit_morphology | 1.23892477 |
| 85 | MP0003724_increased_susceptibility_to | 1.23831123 |
| 86 | MP0001873_stomach_inflammation | 1.22795974 |
| 87 | MP0005171_absent_coat_pigmentation | 1.22671869 |
| 88 | MP0010155_abnormal_intestine_physiology | 1.21321704 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 1.21217847 |
| 90 | MP0009672_abnormal_birth_weight | 1.19435158 |
| 91 | MP0005165_increased_susceptibility_to | 1.19030281 |
| 92 | MP0002160_abnormal_reproductive_system | 1.18608721 |
| 93 | MP0001929_abnormal_gametogenesis | 1.17187509 |
| 94 | MP0003646_muscle_fatigue | 1.16659438 |
| 95 | MP0001542_abnormal_bone_strength | 1.14373753 |
| 96 | MP0000689_abnormal_spleen_morphology | 1.12600412 |
| 97 | MP0000358_abnormal_cell_content/ | 1.12485014 |
| 98 | MP0004381_abnormal_hair_follicle | 1.12351158 |
| 99 | MP0003183_abnormal_peptide_metabolism | 1.12329510 |
| 100 | MP0003315_abnormal_perineum_morphology | 1.12207420 |
| 101 | MP0001145_abnormal_male_reproductive | 1.10405628 |
| 102 | MP0002398_abnormal_bone_marrow | 1.09932806 |
| 103 | MP0002722_abnormal_immune_system | 1.09687938 |
| 104 | MP0003119_abnormal_digestive_system | 1.09252648 |
| 105 | MP0003890_abnormal_embryonic-extraembry | 1.08197286 |
| 106 | MP0000703_abnormal_thymus_morphology | 1.05643611 |
| 107 | MP0000653_abnormal_sex_gland | 1.01547507 |
| 108 | MP0002998_abnormal_bone_remodeling | 0.98477751 |
| 109 | MP0005310_abnormal_salivary_gland | 0.98160631 |
| 110 | MP0008874_decreased_physiological_sensi | 0.97185364 |
| 111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95584856 |
| 112 | MP0000920_abnormal_myelination | 0.93941462 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.93442183 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91684216 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.91680808 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.91212848 |
| 117 | MP0001119_abnormal_female_reproductive | 0.89928878 |
| 118 | MP0001849_ear_inflammation | 0.88708298 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.88420104 |
| 120 | MP0003283_abnormal_digestive_organ | 0.88020374 |
| 121 | MP0004197_abnormal_fetal_growth/weight/ | 0.87834417 |
| 122 | MP0001905_abnormal_dopamine_level | 0.87638103 |
| 123 | MP0002254_reproductive_system_inflammat | 0.86714866 |
| 124 | MP0002429_abnormal_blood_cell | 0.86264413 |
| 125 | MP0003186_abnormal_redox_activity | 0.84162077 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.83704486 |
| 127 | MP0002933_joint_inflammation | 0.83394295 |
| 128 | MP0001727_abnormal_embryo_implantation | 0.82313936 |
| 129 | MP0000858_altered_metastatic_potential | 0.82024949 |
| 130 | MP0005389_reproductive_system_phenotype | 0.81761585 |
| 131 | MP0005621_abnormal_cell_physiology | 0.81696142 |
| 132 | MP0003303_peritoneal_inflammation | 0.81403462 |
| 133 | MP0006054_spinal_hemorrhage | 0.81068208 |
| 134 | MP0001293_anophthalmia | 0.80606593 |
| 135 | MP0005384_cellular_phenotype | 0.80323470 |
| 136 | MP0005670_abnormal_white_adipose | 0.79678059 |
| 137 | MP0005395_other_phenotype | 0.79284481 |
| 138 | MP0005330_cardiomyopathy | 0.79236697 |
| 139 | MP0003699_abnormal_female_reproductive | 0.78856646 |
| 140 | MP0003300_gastrointestinal_ulcer | 0.78029290 |
| 141 | MP0009763_increased_sensitivity_to | 0.77841908 |
| 142 | MP0005390_skeleton_phenotype | 0.77305916 |
| 143 | MP0003567_abnormal_fetal_cardiomyocyte | 0.75424319 |
| 144 | MP0003279_aneurysm | 0.73890128 |
| 145 | MP0003705_abnormal_hypodermis_morpholog | 0.72318669 |
| 146 | MP0000681_abnormal_thyroid_gland | 0.70383302 |
| 147 | MP0002269_muscular_atrophy | 0.70201483 |
| 148 | MP0004858_abnormal_nervous_system | 0.70087717 |
| 149 | MP0004133_heterotaxia | 0.69018652 |
| 150 | MP0000716_abnormal_immune_system | 0.68337079 |
| 151 | MP0001919_abnormal_reproductive_system | 0.68094404 |
| 152 | MP0000747_muscle_weakness | 0.67507602 |
| 153 | MP0002161_abnormal_fertility/fecundity | 0.65605078 |
| 154 | MP0001243_abnormal_dermal_layer | 0.65422656 |
| 155 | MP0000598_abnormal_liver_morphology | 0.65112987 |
| 156 | MP0003690_abnormal_glial_cell | 0.63836369 |
| 157 | MP0003879_abnormal_hair_cell | 0.63717101 |
| 158 | MP0003121_genomic_imprinting | 0.63245402 |
| 159 | MP0005174_abnormal_tail_pigmentation | 0.62947462 |
| 160 | MP0003136_yellow_coat_color | 0.58396206 |
| 161 | MP0005023_abnormal_wound_healing | 0.55626823 |
| 162 | MP0008770_decreased_survivor_rate | 0.55420111 |
| 163 | MP0004233_abnormal_muscle_weight | 0.55129356 |
| 164 | MP0005075_abnormal_melanosome_morpholog | 0.52873897 |
| 165 | MP0000477_abnormal_intestine_morphology | 0.51083165 |
| 166 | MP0003698_abnormal_male_reproductive | 0.49867562 |
| 167 | MP0002075_abnormal_coat/hair_pigmentati | 0.49638380 |
| 168 | MP0003866_abnormal_defecation | 0.49630808 |
| 169 | MP0005464_abnormal_platelet_physiology | 0.47753335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 5.72163302 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 5.59405111 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.59405111 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.59405111 |
| 5 | Cerebral hypomyelination (HP:0006808) | 4.98533781 |
| 6 | Abnormality of the anterior horn cell (HP:0006802) | 4.74551728 |
| 7 | Degeneration of anterior horn cells (HP:0002398) | 4.74551728 |
| 8 | Breast hypoplasia (HP:0003187) | 4.40911082 |
| 9 | Patellar aplasia (HP:0006443) | 3.97190640 |
| 10 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.91017707 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.87182951 |
| 12 | Carpal bone hypoplasia (HP:0001498) | 3.69510961 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.64370703 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.53596245 |
| 15 | Premature ovarian failure (HP:0008209) | 3.49738347 |
| 16 | Aplastic anemia (HP:0001915) | 3.48864083 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.44463784 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.33241971 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.32650964 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.32650964 |
| 21 | Microretrognathia (HP:0000308) | 3.32274173 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 3.27862933 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.22724063 |
| 24 | Secondary amenorrhea (HP:0000869) | 3.20935063 |
| 25 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.18729190 |
| 26 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.15818568 |
| 27 | Selective tooth agenesis (HP:0001592) | 3.10204073 |
| 28 | Abnormal number of erythroid precursors (HP:0012131) | 3.09585674 |
| 29 | Loss of speech (HP:0002371) | 3.08360028 |
| 30 | Rough bone trabeculation (HP:0100670) | 3.04968945 |
| 31 | Obstructive lung disease (HP:0006536) | 3.01773026 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01773026 |
| 33 | Impulsivity (HP:0100710) | 2.97216408 |
| 34 | Mediastinal lymphadenopathy (HP:0100721) | 2.95685026 |
| 35 | Progressive muscle weakness (HP:0003323) | 2.94482919 |
| 36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.93968622 |
| 37 | Medulloblastoma (HP:0002885) | 2.93327785 |
| 38 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.92392029 |
| 39 | Increased intramyocellular lipid droplets (HP:0012240) | 2.91511371 |
| 40 | Multiple enchondromatosis (HP:0005701) | 2.90657304 |
| 41 | Axonal loss (HP:0003447) | 2.89312823 |
| 42 | CNS hypomyelination (HP:0003429) | 2.88098427 |
| 43 | Chromsome breakage (HP:0040012) | 2.87510193 |
| 44 | Ragged-red muscle fibers (HP:0003200) | 2.84832803 |
| 45 | Recurrent bacterial skin infections (HP:0005406) | 2.82761404 |
| 46 | Increased IgM level (HP:0003496) | 2.81751703 |
| 47 | Meckel diverticulum (HP:0002245) | 2.81305818 |
| 48 | Systemic lupus erythematosus (HP:0002725) | 2.81206776 |
| 49 | Oral leukoplakia (HP:0002745) | 2.81130585 |
| 50 | Unsteady gait (HP:0002317) | 2.80821864 |
| 51 | Mutism (HP:0002300) | 2.79713080 |
| 52 | Purpura (HP:0000979) | 2.75366753 |
| 53 | Increased muscle lipid content (HP:0009058) | 2.74257315 |
| 54 | Overlapping toe (HP:0001845) | 2.73724341 |
| 55 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73315487 |
| 56 | Petechiae (HP:0000967) | 2.72130500 |
| 57 | Colon cancer (HP:0003003) | 2.68992255 |
| 58 | Disinhibition (HP:0000734) | 2.68899507 |
| 59 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.67521256 |
| 60 | Abnormality of the ileum (HP:0001549) | 2.67409048 |
| 61 | Slender long bone (HP:0003100) | 2.66856242 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.65590611 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.65546272 |
| 64 | Abnormality of the preputium (HP:0100587) | 2.64125473 |
| 65 | Trismus (HP:0000211) | 2.61781822 |
| 66 | Reticulocytopenia (HP:0001896) | 2.61386600 |
| 67 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.57535573 |
| 68 | Hepatosplenomegaly (HP:0001433) | 2.53625142 |
| 69 | Apathy (HP:0000741) | 2.52745330 |
| 70 | Progressive neurologic deterioration (HP:0002344) | 2.48552613 |
| 71 | Neuronal loss in central nervous system (HP:0002529) | 2.48506929 |
| 72 | Diminished motivation (HP:0000745) | 2.48247328 |
| 73 | Increased serum ferritin (HP:0003281) | 2.45991298 |
| 74 | Prolonged neonatal jaundice (HP:0006579) | 2.45380105 |
| 75 | Muscle fiber atrophy (HP:0100295) | 2.44144727 |
| 76 | Stomatitis (HP:0010280) | 2.42359543 |
| 77 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.41533063 |
| 78 | Abnormality of the labia minora (HP:0012880) | 2.40571102 |
| 79 | Personality changes (HP:0000751) | 2.40254919 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38139548 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38139548 |
| 82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38139548 |
| 83 | Neurofibrillary tangles (HP:0002185) | 2.36756344 |
| 84 | Prominent nose (HP:0000448) | 2.34120537 |
| 85 | Testicular atrophy (HP:0000029) | 2.34003886 |
| 86 | Mesangial abnormality (HP:0001966) | 2.32765819 |
| 87 | Abnormality of the motor neurons (HP:0002450) | 2.32063280 |
| 88 | Abnormal neuron morphology (HP:0012757) | 2.32063280 |
| 89 | Delusions (HP:0000746) | 2.31310563 |
| 90 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.27350681 |
| 91 | Bone marrow hypocellularity (HP:0005528) | 2.27238493 |
| 92 | Macrocytic anemia (HP:0001972) | 2.24666062 |
| 93 | Small intestinal stenosis (HP:0012848) | 2.23618273 |
| 94 | Duodenal stenosis (HP:0100867) | 2.23618273 |
| 95 | Pallor (HP:0000980) | 2.22643430 |
| 96 | Myelodysplasia (HP:0002863) | 2.21310320 |
| 97 | Hepatocellular necrosis (HP:0001404) | 2.18052282 |
| 98 | Ependymoma (HP:0002888) | 2.17546234 |
| 99 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.16787378 |
| 100 | Death in infancy (HP:0001522) | 2.16667042 |
| 101 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.16391230 |
| 102 | Mitochondrial inheritance (HP:0001427) | 2.15679561 |
| 103 | Neoplasm of the pancreas (HP:0002894) | 2.15650974 |
| 104 | Horseshoe kidney (HP:0000085) | 2.15423904 |
| 105 | Breast aplasia (HP:0100783) | 2.15140713 |
| 106 | Mucopolysacchariduria (HP:0008155) | 2.14844629 |
| 107 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14844629 |
| 108 | Absent radius (HP:0003974) | 2.14186821 |
| 109 | Absent thumb (HP:0009777) | 2.13303639 |
| 110 | Achilles tendon contracture (HP:0001771) | 2.12721103 |
| 111 | Upper motor neuron abnormality (HP:0002127) | 2.12448896 |
| 112 | Type 2 muscle fiber atrophy (HP:0003554) | 2.11542202 |
| 113 | Renal Fanconi syndrome (HP:0001994) | 2.10367629 |
| 114 | J-shaped sella turcica (HP:0002680) | 2.10351911 |
| 115 | Sloping forehead (HP:0000340) | 2.08892063 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.08890983 |
| 117 | Abnormality of alanine metabolism (HP:0010916) | 2.08890983 |
| 118 | Hyperalaninemia (HP:0003348) | 2.08890983 |
| 119 | Postnatal microcephaly (HP:0005484) | 2.07739718 |
| 120 | Visual hallucinations (HP:0002367) | 2.07662088 |
| 121 | Thrombocytosis (HP:0001894) | 2.06438651 |
| 122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06122539 |
| 123 | Abnormality of chromosome stability (HP:0003220) | 2.06067502 |
| 124 | Amyloidosis (HP:0011034) | 2.05692388 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 2.05236466 |
| 126 | Nuclear cataract (HP:0100018) | 2.05050673 |
| 127 | Cutaneous melanoma (HP:0012056) | 2.04848208 |
| 128 | Distal lower limb muscle weakness (HP:0009053) | 2.03625271 |
| 129 | Hypertensive crisis (HP:0100735) | 2.03123578 |
| 130 | Supranuclear gaze palsy (HP:0000605) | 2.01652849 |
| 131 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.01348449 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 1.99999883 |
| 133 | Cholecystitis (HP:0001082) | 1.99999883 |
| 134 | Recurrent fungal infections (HP:0002841) | 1.99888502 |
| 135 | Meningitis (HP:0001287) | 1.99582418 |
| 136 | Premature graying of hair (HP:0002216) | 1.99347166 |
| 137 | Recurrent skin infections (HP:0001581) | 1.99262288 |
| 138 | Abnormal trabecular bone morphology (HP:0100671) | 1.98936416 |
| 139 | Abnormal spermatogenesis (HP:0008669) | 1.98923622 |
| 140 | Emotional lability (HP:0000712) | 1.97729540 |
| 141 | Tetraplegia (HP:0002445) | 1.97568342 |
| 142 | Atresia of the external auditory canal (HP:0000413) | 1.97301553 |
| 143 | Cellulitis (HP:0100658) | 1.97287673 |
| 144 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.97170812 |
| 145 | Sparse eyelashes (HP:0000653) | 1.96219543 |
| 146 | Pancreatic fibrosis (HP:0100732) | 1.94925945 |
| 147 | Agammaglobulinemia (HP:0004432) | 1.94669843 |
| 148 | Absent forearm bone (HP:0003953) | 1.94351120 |
| 149 | Aplasia involving forearm bones (HP:0009822) | 1.94351120 |
| 150 | Hypergammaglobulinemia (HP:0010702) | 1.93882248 |
| 151 | Dementia (HP:0000726) | 1.93767395 |
| 152 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.93590177 |
| 153 | Recurrent cutaneous fungal infections (HP:0011370) | 1.92119912 |
| 154 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.92119912 |
| 155 | Tracheoesophageal fistula (HP:0002575) | 1.92055842 |
| 156 | Annular pancreas (HP:0001734) | 1.90686760 |
| 157 | Tongue fasciculations (HP:0001308) | 1.89935706 |
| 158 | Pancreatic cysts (HP:0001737) | 1.89887178 |
| 159 | Increased serum lactate (HP:0002151) | 1.89387596 |
| 160 | CNS demyelination (HP:0007305) | 1.89372959 |
| 161 | Deformed tarsal bones (HP:0008119) | 1.88639922 |
| 162 | Combined immunodeficiency (HP:0005387) | 1.88475177 |
| 163 | Entropion (HP:0000621) | 1.86684273 |
| 164 | Hyperglycinemia (HP:0002154) | 1.84470254 |
| 165 | Megaloblastic anemia (HP:0001889) | 1.82308451 |
| 166 | Cleft eyelid (HP:0000625) | 1.82229367 |
| 167 | Hepatic necrosis (HP:0002605) | 1.82184288 |
| 168 | Recurrent viral infections (HP:0004429) | 1.81015814 |
| 169 | Abnormality of the duodenum (HP:0002246) | 1.80650922 |
| 170 | Abnormality of the Achilles tendon (HP:0005109) | 1.80396987 |
| 171 | Acute necrotizing encephalopathy (HP:0006965) | 1.79288280 |
| 172 | Urticaria (HP:0001025) | 1.79111296 |
| 173 | Cellular immunodeficiency (HP:0005374) | 1.77830255 |
| 174 | Muscle fibrillation (HP:0010546) | 1.77283823 |
| 175 | Patent foramen ovale (HP:0001655) | 1.77127955 |
| 176 | Areflexia of lower limbs (HP:0002522) | 1.76772281 |
| 177 | Joint stiffness (HP:0001387) | 1.75483931 |
| 178 | Polygenic inheritance (HP:0010982) | 1.75187910 |
| 179 | Increased CSF lactate (HP:0002490) | 1.74244288 |
| 180 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.73293060 |
| 181 | Pancytopenia (HP:0001876) | 1.73007493 |
| 182 | Type I transferrin isoform profile (HP:0003642) | 1.72239551 |
| 183 | Myositis (HP:0100614) | 1.72061014 |
| 184 | Triphalangeal thumb (HP:0001199) | 1.72012869 |
| 185 | Spastic paraparesis (HP:0002313) | 1.71825661 |
| 186 | Hyperglycinuria (HP:0003108) | 1.70175351 |
| 187 | True hermaphroditism (HP:0010459) | 1.69520867 |
| 188 | Short thumb (HP:0009778) | 1.68949035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.44502663 |
| 2 | PLK4 | 3.42999067 |
| 3 | VRK2 | 3.36281472 |
| 4 | WEE1 | 3.33760571 |
| 5 | NEK2 | 3.11332981 |
| 6 | TESK2 | 3.10933829 |
| 7 | EIF2AK1 | 2.91322035 |
| 8 | BRSK2 | 2.76255339 |
| 9 | NME2 | 2.65304529 |
| 10 | CDC7 | 2.36287764 |
| 11 | ERN1 | 2.23099445 |
| 12 | TTK | 2.21520896 |
| 13 | TSSK6 | 2.07879810 |
| 14 | NEK1 | 2.05147056 |
| 15 | SMG1 | 1.99006819 |
| 16 | BRSK1 | 1.97851590 |
| 17 | TAOK2 | 1.96603257 |
| 18 | PLK1 | 1.96260286 |
| 19 | RPS6KA4 | 1.95380368 |
| 20 | PRPF4B | 1.92308335 |
| 21 | SRPK1 | 1.89428610 |
| 22 | CCNB1 | 1.89181815 |
| 23 | DYRK3 | 1.88141339 |
| 24 | STK16 | 1.85227523 |
| 25 | TBK1 | 1.81169621 |
| 26 | ACVR1B | 1.78959580 |
| 27 | LATS2 | 1.70994946 |
| 28 | TRIB3 | 1.70192939 |
| 29 | RIPK4 | 1.54743470 |
| 30 | TLK1 | 1.46679267 |
| 31 | PLK3 | 1.42659223 |
| 32 | AURKB | 1.41063638 |
| 33 | SCYL2 | 1.39474449 |
| 34 | BLK | 1.36073608 |
| 35 | EIF2AK3 | 1.32549831 |
| 36 | EPHA2 | 1.28585794 |
| 37 | BRAF | 1.28557077 |
| 38 | CAMKK2 | 1.26850147 |
| 39 | MAP3K12 | 1.21449893 |
| 40 | TESK1 | 1.20736478 |
| 41 | ALK | 1.20579205 |
| 42 | IKBKB | 1.20237828 |
| 43 | FES | 1.19828676 |
| 44 | AURKA | 1.19550552 |
| 45 | TXK | 1.17831305 |
| 46 | VRK1 | 1.17409054 |
| 47 | RPS6KB2 | 1.17304880 |
| 48 | CDK7 | 1.15975716 |
| 49 | MAP3K8 | 1.15696770 |
| 50 | CHEK2 | 1.12694599 |
| 51 | PAK4 | 1.12123155 |
| 52 | ATR | 1.10144460 |
| 53 | STK10 | 1.08685910 |
| 54 | KDR | 1.07607279 |
| 55 | MAP2K3 | 1.07148805 |
| 56 | MKNK1 | 1.03265449 |
| 57 | MKNK2 | 0.97417375 |
| 58 | MAP3K11 | 0.97411533 |
| 59 | CDK4 | 0.96724731 |
| 60 | CSK | 0.94309253 |
| 61 | CHEK1 | 0.92028785 |
| 62 | EEF2K | 0.89774404 |
| 63 | IKBKE | 0.89365258 |
| 64 | MAP3K14 | 0.88215013 |
| 65 | PAK1 | 0.86760588 |
| 66 | BCKDK | 0.86750099 |
| 67 | STK38L | 0.84372424 |
| 68 | TAOK1 | 0.82061151 |
| 69 | CSF1R | 0.81772290 |
| 70 | ZAP70 | 0.81540603 |
| 71 | CDK11A | 0.79049252 |
| 72 | CDK15 | 0.75448256 |
| 73 | PKN2 | 0.75396395 |
| 74 | MAPKAPK3 | 0.74922596 |
| 75 | IRAK4 | 0.74036642 |
| 76 | MAP3K3 | 0.73926260 |
| 77 | LRRK2 | 0.73794554 |
| 78 | IRAK2 | 0.73060222 |
| 79 | MAP4K1 | 0.72891710 |
| 80 | ZAK | 0.72841321 |
| 81 | CDK2 | 0.72154160 |
| 82 | CDK14 | 0.71890548 |
| 83 | CDK18 | 0.71725407 |
| 84 | SYK | 0.71683124 |
| 85 | AKT3 | 0.70204840 |
| 86 | GRK6 | 0.70134108 |
| 87 | MAP2K2 | 0.70081244 |
| 88 | TNK2 | 0.69927863 |
| 89 | MAP3K1 | 0.69745700 |
| 90 | PIM2 | 0.69454777 |
| 91 | SIK3 | 0.69108828 |
| 92 | LIMK1 | 0.68606625 |
| 93 | MAP3K10 | 0.68369672 |
| 94 | CDK8 | 0.66728288 |
| 95 | MAPK11 | 0.65285239 |
| 96 | DYRK2 | 0.64515998 |
| 97 | SIK2 | 0.62923948 |
| 98 | CDK12 | 0.60397733 |
| 99 | CSNK1G3 | 0.60131308 |
| 100 | BMX | 0.58760160 |
| 101 | MOS | 0.58013878 |
| 102 | CSNK2A1 | 0.57211716 |
| 103 | PRKD3 | 0.57100263 |
| 104 | CDK19 | 0.56717488 |
| 105 | ARAF | 0.56032438 |
| 106 | PAK6 | 0.55979116 |
| 107 | PASK | 0.55903313 |
| 108 | YES1 | 0.55536902 |
| 109 | CSNK2A2 | 0.55211836 |
| 110 | ABL2 | 0.52926333 |
| 111 | IRAK3 | 0.51812710 |
| 112 | AKT2 | 0.51754178 |
| 113 | ILK | 0.50719814 |
| 114 | NME1 | 0.49601906 |
| 115 | LYN | 0.49359359 |
| 116 | PIM1 | 0.48416686 |
| 117 | MAP3K13 | 0.47372271 |
| 118 | BTK | 0.47162551 |
| 119 | RPS6KA5 | 0.46025185 |
| 120 | KIT | 0.45776905 |
| 121 | GRK7 | 0.45389267 |
| 122 | FGR | 0.45005647 |
| 123 | PDPK1 | 0.44348374 |
| 124 | * CDK1 | 0.44178999 |
| 125 | CSNK1A1L | 0.44151080 |
| 126 | CAMK2G | 0.41991987 |
| 127 | PDK3 | 0.41677500 |
| 128 | PDK4 | 0.41677500 |
| 129 | MARK3 | 0.41528519 |
| 130 | TYRO3 | 0.40015689 |
| 131 | JAK3 | 0.39240348 |
| 132 | PRKCI | 0.38878962 |
| 133 | LCK | 0.35925377 |
| 134 | TYK2 | 0.34755296 |
| 135 | TGFBR2 | 0.34397704 |
| 136 | ATM | 0.33143884 |
| 137 | MAPKAPK2 | 0.32943498 |
| 138 | SIK1 | 0.32876328 |
| 139 | BMPR2 | 0.32765563 |
| 140 | CDK9 | 0.32561777 |
| 141 | MAP3K5 | 0.31512090 |
| 142 | GRK5 | 0.31110031 |
| 143 | CAMKK1 | 0.30568433 |
| 144 | HCK | 0.30124287 |
| 145 | RIPK1 | 0.29804651 |
| 146 | DAPK3 | 0.29671491 |
| 147 | DAPK1 | 0.29502323 |
| 148 | MATK | 0.28886847 |
| 149 | CSNK1E | 0.28508000 |
| 150 | MAPK4 | 0.28282834 |
| 151 | PINK1 | 0.27755515 |
| 152 | LMTK2 | 0.26913880 |
| 153 | STK4 | 0.26101694 |
| 154 | TGFBR1 | 0.24669765 |
| 155 | PRKD2 | 0.23067999 |
| 156 | RAF1 | 0.22943035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.36414890 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 4.05426424 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 4.01723096 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.79049003 |
| 5 | Spliceosome_Homo sapiens_hsa03040 | 3.53004648 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 3.48217175 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 3.26753518 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 3.23537775 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 3.22172677 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 3.12204012 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.78465955 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.55540559 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.54421796 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 2.51978826 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 2.50572068 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.35820318 |
| 17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.25010506 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 2.20850949 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.19938303 |
| 20 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.18998485 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.14764648 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.09150182 |
| 23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.99939206 |
| 24 | Salmonella infection_Homo sapiens_hsa05132 | 1.89389199 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87960122 |
| 26 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81827592 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.79459457 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.76357033 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71047214 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.70384720 |
| 31 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.67361241 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.67233323 |
| 33 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.62557114 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62556947 |
| 35 | Purine metabolism_Homo sapiens_hsa00230 | 1.58091008 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57415087 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54895946 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.50331358 |
| 39 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.48590832 |
| 40 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.46827309 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.46123615 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.43158532 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41939441 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.41912532 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40287358 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.37234937 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.36944648 |
| 48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35514588 |
| 49 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.33225812 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.26334467 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24516814 |
| 52 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24490469 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24439564 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.23368240 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23186038 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22076895 |
| 57 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.19749431 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18201006 |
| 59 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.16975389 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 1.16941034 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 1.16274345 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16022699 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.10018148 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09232403 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08128712 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 1.05768926 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03228921 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01925298 |
| 69 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.01077730 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.00350064 |
| 71 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99315201 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.99311076 |
| 73 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96639106 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.96245082 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93969583 |
| 76 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93963104 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93383818 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91440743 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88022524 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.87977907 |
| 81 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.87460847 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86735975 |
| 83 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84948056 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84408675 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83494953 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82263895 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79606399 |
| 88 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78887423 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78689275 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.77754117 |
| 91 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75067411 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72583407 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71946128 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67336871 |
| 95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.65374169 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62171312 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61712630 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.58843255 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57214361 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53485113 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52504581 |
| 102 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50783056 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.45761763 |
| 104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.45255003 |
| 105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44412031 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44153852 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43130664 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43104412 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43084309 |
| 110 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42409221 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.40111514 |
| 112 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38667106 |
| 113 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38472121 |
| 114 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36996576 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36136124 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.35874659 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34186968 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.33450148 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32799758 |
| 120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32430651 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30845687 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30774130 |
| 123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30704999 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30617730 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.29304467 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.29027389 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28643413 |
| 128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.27031449 |
| 129 | Parkinsons disease_Homo sapiens_hsa05012 | 0.26346949 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.26328543 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25249459 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24448074 |
| 133 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.23912612 |
| 134 | Bladder cancer_Homo sapiens_hsa05219 | 0.22872518 |
| 135 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.20219405 |
| 136 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.20012456 |
| 137 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19642003 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.15704300 |
| 139 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14754306 |
| 140 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.13454500 |
| 141 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.12501596 |
| 142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.12390218 |
| 143 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.11586538 |
| 144 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.11260972 |
| 145 | Protein export_Homo sapiens_hsa03060 | 0.11110472 |
| 146 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.09972729 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09770060 |
| 148 | Hepatitis B_Homo sapiens_hsa05161 | 0.09072987 |
| 149 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.08915945 |
| 150 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.07845566 |
| 151 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.06596408 |
| 152 | Measles_Homo sapiens_hsa05162 | 0.06537956 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06032681 |
| 154 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.05590036 |
| 155 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.04877963 |
| 156 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.04627872 |

